1. Home
  2. FFAI vs TNXP Comparison

FFAI vs TNXP Comparison

Compare FFAI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFAI
  • TNXP
  • Stock Information
  • Founded
  • FFAI 2014
  • TNXP 2007
  • Country
  • FFAI United States
  • TNXP United States
  • Employees
  • FFAI N/A
  • TNXP N/A
  • Industry
  • FFAI
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFAI
  • TNXP Health Care
  • Exchange
  • FFAI NYSE
  • TNXP Nasdaq
  • Market Cap
  • FFAI 111.5M
  • TNXP 207.5M
  • IPO Year
  • FFAI N/A
  • TNXP N/A
  • Fundamental
  • Price
  • FFAI $1.15
  • TNXP $39.78
  • Analyst Decision
  • FFAI
  • TNXP Strong Buy
  • Analyst Count
  • FFAI 0
  • TNXP 2
  • Target Price
  • FFAI N/A
  • TNXP $585.00
  • AVG Volume (30 Days)
  • FFAI 6.1M
  • TNXP 1.3M
  • Earning Date
  • FFAI 05-08-2025
  • TNXP 05-12-2025
  • Dividend Yield
  • FFAI N/A
  • TNXP N/A
  • EPS Growth
  • FFAI N/A
  • TNXP N/A
  • EPS
  • FFAI N/A
  • TNXP N/A
  • Revenue
  • FFAI $853,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • FFAI $115,335.99
  • TNXP $12.17
  • Revenue Next Year
  • FFAI N/A
  • TNXP $789.15
  • P/E Ratio
  • FFAI N/A
  • TNXP N/A
  • Revenue Growth
  • FFAI 8.52
  • TNXP N/A
  • 52 Week Low
  • FFAI $0.83
  • TNXP $6.76
  • 52 Week High
  • FFAI $31.40
  • TNXP $558.08
  • Technical
  • Relative Strength Index (RSI)
  • FFAI N/A
  • TNXP 74.56
  • Support Level
  • FFAI N/A
  • TNXP $25.40
  • Resistance Level
  • FFAI N/A
  • TNXP $37.84
  • Average True Range (ATR)
  • FFAI 0.00
  • TNXP 4.17
  • MACD
  • FFAI 0.00
  • TNXP 1.75
  • Stochastic Oscillator
  • FFAI 0.00
  • TNXP 87.00

About FFAI FARADAY FUTURE INTELLIGENT ELEC INC

Faraday Future Intelligent Electric Inc is a shared intelligent mobility ecosystem. The company is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models. The company has additional engineering, sales, and operational capabilities in China and plans to develop its manufacturing capability in China through a joint venture.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: